US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion NVDA Defined Income Boost ETF

28.71

+0.06000.21%

Volume:208

Turnover:5.98K

Market Cap:2.58M

PE:- -

High:28.78

Open:28.78

Low:28.71

Close:28.65

52wk High:29.89

52wk Low:24.54

Shares:90.00K

Float Shares:90.00K

Volume Ratio:1.95

T/O Rate:0.23%

Dividend:0.92

Dividend Rate:3.20%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Why is Alector Stock (ALEC) 60% Higher Today?

Celcuity Announces Multiple Presentations At The European Society For Medical Oncology (ESMO) Congress 2026

Percheron Therapeutics Names New CEO to Drive Oncology Strategy and Investor Outreach

Candel Therapeutics to Present at the SITC 2026 Annual Meeting

Press Release: Celcuity Appoints David Gryska to Its Board of Directors

Verastem announces data from analysis of Phase 2 RAMP 201 trial

Summit Therapeutics enters trial collaboration with AstraZeneca, Daiichi Sankyo

BICO folds Cellenion into SCIENION to sharpen precision biotech focus

Nanobiotix taps veteran biotech CFO Arnd Christ to steer next growth phase

Mineralys Therapeutics Announces Presentation of Lorundrostat Data at American Heart Association Hypertension Scientific Sessions 2026

Mizuho biotech analysts hold an analyst/industry conference call

JPMorgan SMid biotech analysts hold an analyst/industry conference call

AIM ImmunoTech Spotlights Growing Attention Around Ampligen® Pancreatic Cancer Strategy as DURIPANC Advances Toward Topline Data

Veeva supporting transformation of medicine through AI, Barron’s reports

Kailera Therapeutics Presents New Clinical Data at EASD 2026 Annual Meeting

RYUK-IL C&S pivots to biotech and pet markets with sweeping charter changes

Corvus announces initiation of Phase 1b clinical trial of soquelitinib

Why Is Penny Stock Connect Biopharma (CNTB) Up 98% Today?

Celcuity Announces That REVTORPYK™ (gedatolisib) Is Now Commercially Available In The United States

Satellos announces enrollment completed for BASECAMP

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/NVIB/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NVIB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVIB\",,,,,undefined,":{"symbol":"NVIB","market":"US","secType":"STK","nameCN":"Direxion NVDA Defined Income Boost ETF","latestPrice":28.711,"timestamp":1791556963063,"preClose":28.651,"halted":0,"volume":208,"delay":0,"changeRate":0.0020941677428361564,"floatShares":90001,"shares":90001,"eps":0,"marketStatus":"Trading","change":0.06,"latestTime":"10-09 10:48:47 EDT","open":28.775,"high":28.775,"low":28.711,"amount":5978.427519999999,"amplitude":0.002234,"askPrice":28.72,"askSize":100,"bidPrice":28.65,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1791576000000},"marketStatusCode":2,"adr":0,"listingDate":1785297600000,"exchange":"CBOE","adjPreClose":28.651,"nav":29.611,"aum":2664977.22,"dividendRate":0.031981,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":29.6504,"preClose":28.651,"latestTime":"16:10 EDT","volume":6,"amount":171.906,"timestamp":1791490204365,"change":0.9994,"changeRate":0.034882,"amplitude":0},"volumeRatio":1.946238},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVIB\",,,,,undefined,":{"symbol":"NVIB","floatShares":90001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.946238,"shares":90001,"dividePrice":0.9182,"high":28.775,"amplitude":0.002234,"preClose":28.651,"low":28.711,"week52Low":24.54,"pbRate":"--","week52High":29.89,"institutionHeld":0,"latestPrice":28.711,"eps":0,"divideRate":0.031981,"volume":208,"delay":0,"ttmEps":0,"open":28.775,"prevYearClose":25,"prevWeekClose":29.1392,"prevMonthClose":28.4278,"prevQuarterClose":28.4278,"fiveDayClose":29.1392,"twentyDayClose":27.3696},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NVIB\",params:#limit:5,,,undefined,":[{"date":"2026-09-30","symbol":"NVIB","amount":0.23782,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-30","defaultRemindTime":1790775000000,"name":"Direxion NVDA Defined Income Boost ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-10-01","payableDate":"2026-09-30","currency":"USD","dateTimestamp":1790740800000,"payDate":"2026-10-01"},{"date":"2026-09-15","symbol":"NVIB","amount":0.22766,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-15","defaultRemindTime":1789479000000,"name":"Direxion NVDA Defined Income Boost ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-16","payableDate":"2026-09-15","currency":"USD","dateTimestamp":1789444800000,"payDate":"2026-09-16"},{"date":"2026-08-28","symbol":"NVIB","amount":0.21733,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-08-28","defaultRemindTime":1787923800000,"name":"Direxion NVDA Defined Income Boost ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-08-31","payableDate":"2026-08-28","currency":"USD","dateTimestamp":1787889600000,"payDate":"2026-08-31"},{"date":"2026-08-14","symbol":"NVIB","amount":0.23454,"announcedDate":"2026-08-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-08-14","defaultRemindTime":1786714200000,"name":"Direxion NVDA Defined Income Boost ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-08-17","payableDate":"2026-08-14","currency":"USD","dateTimestamp":1786680000000,"payDate":"2026-08-17"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NVIB\",market:\"US\",,,undefined,":[{"executeDate":"2026-08-14","recordDate":"2026-08-14","paymentDate":"2026-08-17","value":0.23454,"currency":"USD"},{"executeDate":"2026-08-28","recordDate":"2026-08-28","paymentDate":"2026-08-31","value":0.21733,"currency":"USD"},{"executeDate":"2026-09-15","recordDate":"2026-09-15","paymentDate":"2026-09-16","value":0.22766,"currency":"USD"},{"executeDate":"2026-09-30","recordDate":"2026-09-30","paymentDate":"2026-10-01","value":0.23782,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NVIB\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NVIB\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673700156","title":"Why is Alector Stock (ALEC) 60% Higher Today?","url":"https://stock-news.laohu8.com/highlight/detail?id=2673700156","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673700156?lang=en_us&edition=fundamental","pubTime":"2026-10-05 21:18","pubTimestamp":1791206284,"startTime":"0","endTime":"0","summary":"Shares in U.S biotech firm Alector ($ALEC) surged 60% in pre-market trading today after Swiss drugmaker Roche ($RHHBY) agreed to pay up to $1.27 to...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/why-is-alector-stock-alec-60-higher-today?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/why-is-alector-stock-alec-60-higher-today?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVIB","ALEC","BK4139","XBIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673470274","title":"Celcuity Announces Multiple Presentations At The European Society For Medical Oncology (ESMO) Congress 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2673470274","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673470274?lang=en_us&edition=fundamental","pubTime":"2026-10-05 20:00","pubTimestamp":1791201600,"startTime":"0","endTime":"0","summary":"Rapid oral presentation of additional sub-group analyses from the VIKTORIA-1 PIK3CA mutant-type cohort Poster presentation of a comparative analysis of data for the gedatolisib triplet from the PIK3CA","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/05/3374475/0/en/celcuity-announces-multiple-presentations-at-the-european-society-for-medical-oncology-esmo-congress-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0240877869.USD","BK4588","LU0240878834.USD","TNGY","BK4135","BK4561","EPV","AMLP","AMZA","BK4581","IE00BHPRN162.USD","BK4585","GDOC","UMI","EIPI","NVIB","BK4144","ENFR","IDNA","EMLP","TPZ","BK4590","MLPA","USAI","WT","EIPX","ET","MDST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673768757","title":"Percheron Therapeutics Names New CEO to Drive Oncology Strategy and Investor Outreach","url":"https://stock-news.laohu8.com/highlight/detail?id=2673768757","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673768757?lang=en_us&edition=fundamental","pubTime":"2026-10-05 05:59","pubTimestamp":1791151185,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Percheron Therapeutics ( ($AU:PER) ). Percheron Therapeutics has appointed experienced biotech executive Dr Mic...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/percheron-therapeutics-names-new-ceo-to-drive-oncology-strategy-and-investor-outreach?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/percheron-therapeutics-names-new-ceo-to-drive-oncology-strategy-and-investor-outreach?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4539","XBIX","NVIB","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672591712","title":"Candel Therapeutics to Present at the SITC 2026 Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2672591712","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672591712?lang=en_us&edition=fundamental","pubTime":"2026-10-02 21:00","pubTimestamp":1790946000,"startTime":"0","endTime":"0","summary":"NEEDHAM, Mass., Oct.  02, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal immunot","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/02/3373820/0/en/candel-therapeutics-to-present-at-the-sitc-2026-annual-meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999011746.SGD","IE00BYQNZ168.SGD","IDNA","NVIB","BK4231","IE00BYTNYN87.SGD","GDOC","CADL","BK1103","MEDX","IE00B12V2V27.USD","IE0003795394.USD","BK4109","01308","BOAT","DNA","HYLG","IE0003851619.USD","BK4139","BK1541","LU1880383366.USD","LU1880383440.USD","BK4121","BK4080","SEA","SITC","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672116477","title":"Press Release: Celcuity Appoints David Gryska to Its Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2672116477","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672116477?lang=en_us&edition=fundamental","pubTime":"2026-10-02 20:00","pubTimestamp":1790942400,"startTime":"0","endTime":"0","summary":"MINNEAPOLIS, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a biotechnology company focused on developing and commercializing targeted therapies for the treatment of multiple solid tu","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDX","BK4139","BK4604","GDOC","BK4099","CELC","TM","BK4555","BK4588","NVIB","HYLG","IDNA","BBP","IEIH","SYNB","RSPH","IBB","BK4585","03160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672005719","title":"Verastem announces data from analysis of Phase 2 RAMP 201 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2672005719","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672005719?lang=en_us&edition=fundamental","pubTime":"2026-10-02 19:35","pubTimestamp":1790940914,"startTime":"0","endTime":"0","summary":"Verastem (VSTM) Oncology announced data from a new molecular profiling and tumor biomarker analysis of the Phase 2 RAMP 201 clinical trial of avuto...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/verastem-announces-data-from-analysis-of-phase-2-ramp-201-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/verastem-announces-data-from-analysis-of-phase-2-ramp-201-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MEDX","BK4139","IDNA","NVIB","GDOC","HYLG","VSTM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672107715","title":"Summit Therapeutics enters trial collaboration with AstraZeneca, Daiichi Sankyo","url":"https://stock-news.laohu8.com/highlight/detail?id=2672107715","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672107715?lang=en_us&edition=fundamental","pubTime":"2026-10-02 17:55","pubTimestamp":1790934913,"startTime":"0","endTime":"0","summary":"Summit Therapeutics (SMMT) announced a clinical trial collaboration agreement with Daiichi Sankyo (DSNKY) and AstraZeneca (AZN) to evaluate ivonesc...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/summit-therapeutics-enters-trial-collaboration-with-astrazeneca-daiichi-sankyo-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/summit-therapeutics-enters-trial-collaboration-with-astrazeneca-daiichi-sankyo-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029864427.USD","LU2456880835.USD","BK4585","LU2237443465.HKD","LU0058720904.USD","LU2468319806.SGD","LU0109394709.USD","MEDX","LU2237443549.SGD","LU2089984988.USD","LU0310800379.SGD","BK4139","HYLG","LU1829250122.USD","BK4588","LU0889565916.HKD","AZNH","GDOC","AZN","LU0708994859.HKD","SMMT","LU0289739699.SGD","DSNKY","LU2236285917.USD","BK4007","LU2462157665.USD","LU2237443978.SGD","IDNA","LENZ","LU0320765992.SGD","LU0432979614.USD","NVIB","LU1267930573.SGD","BK4568","IE00B3T34201.USD","BK4539","LU2237443622.USD","LU0128525929.USD","LU2237443895.HKD","LU2488822045.USD","LU2237443382.USD","LU2417539215.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672991794","title":"BICO folds Cellenion into SCIENION to sharpen precision biotech focus","url":"https://stock-news.laohu8.com/highlight/detail?id=2672991794","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672991794?lang=en_us&edition=fundamental","pubTime":"2026-10-02 13:32","pubTimestamp":1790919176,"startTime":"0","endTime":"0","summary":"BICO Group AB Class B ( ($SE:BICO) ) has issued an announcement. BICO Group AB has completed the integration of single-cell specialist Cellenion in...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bico-folds-cellenion-into-scienion-to-sharpen-precision-biotech-focus?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bico-folds-cellenion-into-scienion-to-sharpen-precision-biotech-focus?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0261945553.USD","LU0737861269.HKD","LU2008162690.USD","LU0516422952.EUR","LU1242518857.USD","SG9999002406.SGD","LU1861220207.SGD","SGXZ58947870.SGD","LU0589944569.HKD","LU2065171311.SGD","SG9999013478.USD","SG9999013460.SGD","XBIX","SG9999014484.SGD","LU0499858438.USD","NVIB","LU2177674079.SGD","LU2152927971.USD","BK4588","LU0289960550.SGD","LU0516422440.USD","BK4503","SE","BK4585","LU0210637038.USD","LU0072462343.USD","BK4551","LU0516423174.USD","SG9999006266.SGD","BK4220","LU0572940350.SGD","LU1861217088.USD","SG9999013486.USD","LU0251143029.SGD","SG9999005177.SGD","BK4085","LU2125910849.SGD","LU0175139822.USD","LU0441851309.USD","LU0532188223.SGD","LU2543165471.USD","FDNI","BK4581","SG9999002620.SGD","LU0345775950.USD","BK4554","LU2360107671.USD","IE0034224299.USD","LU0048573645.USD","LU0499858602.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672629967","title":"Nanobiotix taps veteran biotech CFO Arnd Christ to steer next growth phase","url":"https://stock-news.laohu8.com/highlight/detail?id=2672629967","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672629967?lang=en_us&edition=fundamental","pubTime":"2026-10-02 04:37","pubTimestamp":1790887025,"startTime":"0","endTime":"0","summary":"The latest update is out from Nanobiotix ( ($FR:NANO) ). Nanobiotix is a late‑stage French biotechnology company developing physics‑based therapeut...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nanobiotix-taps-veteran-biotech-cfo-arnd-christ-to-steer-next-growth-phase?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nanobiotix-taps-veteran-biotech-cfo-arnd-christ-to-steer-next-growth-phase?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RSPH","BK4588","XT","AGNG","FWD","NVIB","SYNB","BK4585","IEIH","JDOC","NANO","XBIX","FHLC","IBB","BBP","LNGR","DARP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672764016","title":"Mineralys Therapeutics Announces Presentation of Lorundrostat Data at American Heart Association Hypertension Scientific Sessions 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2672764016","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672764016?lang=en_us&edition=fundamental","pubTime":"2026-10-02 04:05","pubTimestamp":1790885100,"startTime":"0","endTime":"0","summary":"RADNOR, Pa., Oct.  01, 2026 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and aldosterone-related ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/01/3373386/0/en/mineralys-therapeutics-announces-presentation-of-lorundrostat-data-at-american-heart-association-hypertension-scientific-sessions-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDNA","LENZ","BK4117","AFG","BK4539","GDOC","MEDX","NVIB","HYLG","BK4139","BK4107","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672761479","title":"Mizuho biotech analysts hold an analyst/industry conference call","url":"https://stock-news.laohu8.com/highlight/detail?id=2672761479","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672761479?lang=en_us&edition=fundamental","pubTime":"2026-10-02 03:00","pubTimestamp":1790881217,"startTime":"0","endTime":"0","summary":"Biotech AnaLyst Syed, along with the Biotech Research Team, discuss Vaxcyte (PCVX), ahead of VAX-31 Ph3 OPUS-1 readout this October, as well as BBI...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mizuho-biotech-analysts-hold-an-analyst-industry-conference-call-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mizuho-biotech-analysts-hold-an-analyst-industry-conference-call-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","XBI","XBIX","LU0053671581.USD","BK4588","IE0009354923.USD","BK4581","NVIB","PCVX","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672662237","title":"JPMorgan SMid biotech analysts hold an analyst/industry conference call","url":"https://stock-news.laohu8.com/highlight/detail?id=2672662237","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672662237?lang=en_us&edition=fundamental","pubTime":"2026-10-02 00:50","pubTimestamp":1790873411,"startTime":"0","endTime":"0","summary":"SMid Biotechnology Analysts Cheng and Medeiros discuss their view on Kymera Therapeutics’s (KYMR) STATS readout in atopic dermatitis on an Analyst/...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/jpmorgan-smid-biotech-analysts-hold-an-analyst-industry-conference-call-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/jpmorgan-smid-biotech-analysts-hold-an-analyst-industry-conference-call-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FNCL","JPO","IE00BFXG1179.USD","IXG","FTXO","TFNS","LU1244550577.SGD","LU2505996509.AUD","PGF","LU0211326755.USD","LU2236285917.USD","BK4207","LU2054465674.USD","NVIB","IE00BJTD4V19.USD","IE00BZ1G4Q59.USD","LU2213496289.HKD","IYF","LU0943347566.SGD","LU2357627491.SGD","BK4585","JPM","XLF","LU0345769631.USD","LU0106831901.USD","VFH","LU2168564222.USD","TRUF","IYG","IE000BZT7R73.USD","LU0820562030.AUD","LU2168563687.JPY","IE00B3S45H60.SGD","KBWB","LU0320765489.SGD","SG9999002224.SGD","BK4139","LU0234572021.USD","LU1064131342.USD","LU0265550946.USD","LU2552382132.HKD","JPMO","LU0256863902.USD","LU1917777945.USD","LU0971096721.USD","KYMR","IE00BN8TJ469.HKD","LU0238689110.USD","UYG","XBIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672750336","title":"AIM ImmunoTech Spotlights Growing Attention Around Ampligen® Pancreatic Cancer Strategy as DURIPANC Advances Toward Topline Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2672750336","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672750336?lang=en_us&edition=fundamental","pubTime":"2026-10-01 21:02","pubTimestamp":1790859720,"startTime":"0","endTime":"0","summary":"Recent biotech media features focus on Ampligen’s potential to address immune resistance in metastatic pancreatic cancer and the clinical progress of the Phase 2 DURIPANC programOCALA, Fla., Oct.  01,","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/01/3372985/29489/en/aim-immunotech-spotlights-growing-attention-around-ampligen-pancreatic-cancer-strategy-as-duripanc-advances-toward-topline-data.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HYLG","GDOC","IDNA","NVIB","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672579387","title":"Veeva supporting transformation of medicine through AI, Barron’s reports","url":"https://stock-news.laohu8.com/highlight/detail?id=2672579387","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672579387?lang=en_us&edition=fundamental","pubTime":"2026-10-01 20:55","pubTimestamp":1790859332,"startTime":"0","endTime":"0","summary":"AI holds the promise to accelerate drug development, optimize clinical trials, and bring lifesaving therapies to market faster, and Veeva (VEEV) Sy...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/veeva-supporting-transformation-of-medicine-through-ai-barrons-reports-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/veeva-supporting-transformation-of-medicine-through-ai-barrons-reports-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FBT","BK4504","BK4534","IDNA","NVIB","BK4613","EKG","AGIX","VTHR","VEEV","LU0106261372.USD","LU1989764664.SGD","LGHT","LU0170899867.USD","BK4585","BMED","ARTY","LU0006306889.USD","CHAT","LU1989764748.USD","AIPO","MEDX","LU0058720904.USD","HYLG","BK4167","BK4528","BK4588","LU0289739699.SGD","GDOC","LU0266013472.USD","LFSC","QTOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672759490","title":"Kailera Therapeutics Presents New Clinical Data at EASD 2026 Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2672759490","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672759490?lang=en_us&edition=fundamental","pubTime":"2026-10-01 18:45","pubTimestamp":1790851500,"startTime":"0","endTime":"0","summary":"- New Phase 1 data highlight flexibility of injection site for ribupatide injection - Four additional oral presentations from Hengrui Pharma add to the clinical evidence behind Kailera's pipeline WALT","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/01/3372706/0/en/kailera-therapeutics-presents-new-clinical-data-at-easd-2026-annual-meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDX","JDOC","BK4139","OZEM","KLRA","IDNA","NVIB","GDOC","HYLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672739201","title":"RYUK-IL C&S pivots to biotech and pet markets with sweeping charter changes","url":"https://stock-news.laohu8.com/highlight/detail?id=2672739201","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672739201?lang=en_us&edition=fundamental","pubTime":"2026-10-01 11:12","pubTimestamp":1790824358,"startTime":"0","endTime":"0","summary":"RYUK-IL C&S., Ltd. ( ($KR:191410) ) has provided an announcement. RYUK-IL C&S., Ltd. shareholders approved a partial amendment of the Articles of I...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ryuk-il-cs-pivots-to-biotech-and-pet-markets-with-sweeping-charter-changes?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ryuk-il-cs-pivots-to-biotech-and-pet-markets-with-sweeping-charter-changes?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBIX","NVIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672782978","title":"Corvus announces initiation of Phase 1b clinical trial of soquelitinib","url":"https://stock-news.laohu8.com/highlight/detail?id=2672782978","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672782978?lang=en_us&edition=fundamental","pubTime":"2026-10-01 04:10","pubTimestamp":1790799031,"startTime":"0","endTime":"0","summary":"Corvus Pharmaceuticals (CRVS) announced that enrollment has begun in its Phase 1b clinical trial of soquelitinib for the treatment of patients with...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/corvus-announces-initiation-of-phase-1b-clinical-trial-of-soquelitinib-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/corvus-announces-initiation-of-phase-1b-clinical-trial-of-soquelitinib-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CRVS","IDNA","MEDX","BK4568","HYLG","BK4139","NVIB","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671207502","title":"Why Is Penny Stock Connect Biopharma (CNTB) Up 98% Today?","url":"https://stock-news.laohu8.com/highlight/detail?id=2671207502","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671207502?lang=en_us&edition=fundamental","pubTime":"2026-09-30 21:14","pubTimestamp":1790774085,"startTime":"0","endTime":"0","summary":"Connect Biopharma stock rallied over 98% after the company announced new clinical trial data for rademikibart.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/why-is-penny-stock-connect-biopharma-cntb-up-98-today?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/why-is-penny-stock-connect-biopharma-cntb-up-98-today?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["82843","KWEB","82823","NVIB","ASHS","HYLG","YANG","FLCH","GDOC","02823","02843","KCAI","CHAU","CWEB","YINN","YXI","BK4139","FXP","82822","XPP","MEDX","ASHR","KBA","CNTB","IDNA","02822"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671253201","title":"Celcuity Announces That REVTORPYK™ (gedatolisib) Is Now Commercially Available In The United States","url":"https://stock-news.laohu8.com/highlight/detail?id=2671253201","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671253201?lang=en_us&edition=fundamental","pubTime":"2026-09-30 20:00","pubTimestamp":1790769600,"startTime":"0","endTime":"0","summary":"REVTORPYK (gedatolisib)   REVTORPYK (gedatolisib) vial and box  REVTORPYK is indicated for patients with HR+/HER2- advanced breast cancer without a PIK3CA mutation detected following progression on or","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/30/3371842/0/en/celcuity-announces-that-revtorpyk-gedatolisib-is-now-commercially-available-in-the-united-states.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SRET","IDNA","BK4599","BK4203","BK4585","LU1878469433.USD","ALT","BK4588","NVIB","UBCP","BK4139","LABU","BK4225","HR","BK4211","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671726206","title":"Satellos announces enrollment completed for BASECAMP","url":"https://stock-news.laohu8.com/highlight/detail?id=2671726206","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671726206?lang=en_us&edition=fundamental","pubTime":"2026-09-30 19:15","pubTimestamp":1790766924,"startTime":"0","endTime":"0","summary":"Satellos (MSLE) Bioscience announced that enrollment has been completed for BASECAMP, the company’s Phase 2 clinical trial evaluating forazapadin f...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/satellos-announces-enrollment-completed-for-basecamp-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/satellos-announces-enrollment-completed-for-basecamp-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MEDX","GDOC","NVIB","BK4139","MSLE","IDNA","HYLG"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}